Rilotumumab
|
WikiDoc Resources for Rilotumumab |
|
Articles |
|---|
|
Most recent articles on Rilotumumab Most cited articles on Rilotumumab |
|
Media |
|
Powerpoint slides on Rilotumumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Rilotumumab at Clinical Trials.gov Clinical Trials on Rilotumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Rilotumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Rilotumumab Discussion groups on Rilotumumab Patient Handouts on Rilotumumab Directions to Hospitals Treating Rilotumumab Risk calculators and risk factors for Rilotumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Rilotumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Rilotumumab is a human monoclonal antibody and which it is used to treat cancer.